CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 227 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,106 | +45.4% | 114 | +18.8% | 0.00% | – |
| Q2 2023 | $2,136 | -45.2% | 96 | -46.7% | 0.00% | – |
| Q1 2023 | $3,899 | +99.9% | 180 | +87.5% | 0.00% | – |
| Q4 2022 | $1,950 | -78.3% | 96 | -71.8% | 0.00% | -100.0% |
| Q3 2022 | $9,000 | +350.0% | 340 | +254.2% | 0.00% | – |
| Q2 2022 | $2,000 | 0.0% | 96 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | -50.0% | 96 | -50.5% | 0.00% | -100.0% |
| Q4 2021 | $4,000 | +33.3% | 194 | +27.6% | 0.00% | 0.0% |
| Q3 2021 | $3,000 | -57.1% | 152 | -51.6% | 0.00% | -50.0% |
| Q2 2021 | $7,000 | +16.7% | 314 | +33.1% | 0.00% | +100.0% |
| Q1 2021 | $6,000 | +20.0% | 236 | +33.3% | 0.00% | 0.0% |
| Q4 2020 | $5,000 | +150.0% | 177 | +84.4% | 0.00% | 0.0% |
| Q3 2020 | $2,000 | +100.0% | 96 | +92.0% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 50 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | – | 50 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,609,429 | $55,961,000 | 3.12% |
| INVESTOR AB | 1,835,974 | $11,934,000 | 0.86% |
| GLOBEFLEX CAPITAL L P | 244,183 | $1,587,000 | 0.40% |
| Campbell & CO Investment Adviser LLC | 21,446 | $139,000 | 0.37% |
| Birchview Capital, LP | 80,000 | $520,000 | 0.30% |
| FEDERATED HERMES, INC. | 13,879,968 | $90,220,000 | 0.26% |
| MENTA CAPITAL LLC | 388,582 | $2,526,000 | 0.24% |
| Sitrin Capital Management LLC | 40,000 | $260,000 | 0.20% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 172,389 | $1,121,000 | 0.18% |
| GSA CAPITAL PARTNERS LLP | 384,976 | $2,502,000 | 0.13% |